Qiagen N.v. (QGEN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
QGEN Profit Margin, ROE & Profitability Analysis
QGEN vs Healthcare Sector: How Qiagen N.v. Compares
How Qiagen N.v. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Qiagen N.v. Stock Overvalued? QGEN Valuation Analysis 2026
Based on fundamental analysis, Qiagen N.v. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Qiagen N.v. Balance Sheet: QGEN Debt, Cash & Liquidity
QGEN Revenue Growth, EPS Growth & YoY Performance
QGEN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Qiagen N.v. (CIK: 0001015820)
📋 Recent SEC Filings
❓ Frequently Asked Questions about QGEN
What is the AI rating for QGEN?
Qiagen N.v. (QGEN) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are QGEN's key strengths?
Claude: Analysis in progress.
What are the risks of investing in QGEN?
Claude: Analysis in progress.
What is QGEN's revenue and growth?
Qiagen N.v. reported revenue of N/A.
Does QGEN pay dividends?
Qiagen N.v. does not currently pay dividends.
Where can I find QGEN SEC filings?
Official SEC filings for Qiagen N.v. (CIK: 0001015820) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is QGEN's EPS?
Qiagen N.v. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is QGEN's fundamental grade?
Based on our AI fundamental analysis in May 2026, Qiagen N.v. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is QGEN stock overvalued or undervalued?
Valuation metrics for QGEN: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is QGEN's AI grade for 2026?
Our dual AI analysis gives Qiagen N.v. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is QGEN's free cash flow?
Qiagen N.v.'s operating cash flow is N/A, with capital expenditures of N/A.
How does QGEN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).